GlassScriptPhysician profile
Frank Lau
NPI 1164649737
$5,258.61
in general payments reported to CMS, 2019-2025
19 companies · $3,007 in 2025
The $3,007 reported for 2025 was more than what 88% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $88.25 · 2021: $200 · 2022: $861 · 2023: $397 · 2024: $19.92 · 2025: $3,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,525 · Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,524.51 |
| Food and Beverage | $898.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,796.08 | 2024-2025 | |
| Acera Surgical, INC. | $497.42 | 2022-2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $382.96 | 2019-2022 | |
| Polarityte, INC. | $322.95 | 2019-2020 | |
| Sientra, INC. | $258.98 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $204.21 | 2022 | |
| Baxter Healthcare | $146.11 | 2021-2023 | Artiss |
| Abbvie INC. | $122.57 | 2023 | |
| Tela Bio, INC. | $104.11 | 2019 | |
| Kerecis Limited | $96.14 | 2019-2022 | |
| Medline Industries LP | $87.97 | 2019 | |
| Smith+Nephew, INC. | $72.77 | 2019-2022 | |
| Depuy Synthes Sales INC. | $63.66 | 2022 | |
| Zyla Life Sciences, INC. | $30.84 | 2019 | |
| Allergan, INC. | $19.55 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $18.78 | 2022 | |
| Convatec INC. | $17.35 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.16 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Lau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.